CGS-CIMB predicts Pentamaster's future earnings could be impacted by depreciating EV demand due to rising interest rates and subsidy cuts. Growth in the medical segment may offset losses. However, lasting weakness in mobile/semiconductor industry may pose financial challenges.
Pentamaster's ongoing revenue and net profit gains, as well as its diversification, expansion, and R&D investment strategies, underscore its bright outlook. Notably, potential growth lies within the automotive and medical sectors.
槟杰科达股票讨论区
Quarter results update with authors recommended TP
暂无评论